MedPath

Novii External Fetal Monitoring Device

Not Applicable
Completed
Conditions
Pregnancy Related
Fetal Distress
Interventions
Device: Novii ECG/EKG System
Device: External fetal heart rate monitoring
Registration Number
NCT03156608
Lead Sponsor
Intermountain Health Care, Inc.
Brief Summary

This study will be conducted on women in labor. Fetal heart rate monitoring will be conducting using the Novii Fetal ECG/EMG system and comparing it to current standard of care external fetal heart rate and tocometry. These approaches will be compared with the respect to need for additional monitoring, amount of nursing intervention, cost and satisfaction of patients and healthcare providers.

Detailed Description

Interpretation of fetal heart rate monitoring during labor is one of the most common procedures performed in the practice of obstetrics. Continuous monitoring of the fetal heart rate is used to identify infants at risk for hypoxic ischemic encephalopathy and allow for intervention to prevent this terrible complication. The quality of the fetal heart rate signal is critical for appropriate interpretation of the characteristics that identify risk.

This is a prospective, randomized pragmatic trial comparing the Novii Fetal ECG/EMG system to external fetal heart rate and tocometry (standard of care) for the amount of time of interpretable fetal heart rate during labor. Randomization will occur in blocks based on BMI to control for the potential effect of BMI.

Fetal heart rate tracings from both groups of women will be reviewed in a blinded fashion by experienced Maternal Fetal Medicine (MFM) physicians who will assess the tracing for quality and interpretability. In addition, both approaches will be compared with respect to the need for additional monitoring modalities, amount of nursing intervention, cost and satisfaction of the patients and healthcare providers.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
218
Inclusion Criteria
  • Pregnant women ≥ 18 years of age; gestational age ≥ 37 weeks

  • Singleton pregnancy.

  • These women will be those presenting to Labor and Delivery for one of the following:

    • Rule out labor
    • Spontaneous labor
    • Induction of labor
Exclusion Criteria
  • Age < 18 years old; multiple gestation pregnancy; gestational age < 37 weeks
  • Fetal distress or vaginal bleeding prior to monitor placement
  • Previous cesarean section
  • Planned cesarean delivery.
  • Women who are enrolled in the study but have less than 1 hour of fetal heart rate monitoring after randomization will be excluded from analysis.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Novii Device ECG/EMG SystemNovii ECG/EKG SystemThese patients will have the Novii ECG/EMG system placed throughout labor and delivery, unless a provider or investigator determines that a different device (internal or external) is necessary for a better signal.
Standard of Care External MonitorExternal fetal heart rate monitoringA standard external monitor will be placed throughout labor and delivery, unless a provider or investigator determines that an internal device is necessary for a better signal.
Primary Outcome Measures
NameTimeMethod
Amount of time in minutes with the interpretable fetal heart rate tracing during the course of labor.Time of randomization until time of delivery (up to 48 hours)

Quality of the fetal heart rate for each minute of tracing will be assessed visually by 2 or more blinded reviewers. For the purpose of this study, uninterpretable fetal heart rate will be defined as continuous fetal heart rate data with one or more of the following:

1. Data is missing for more than 75% of the minute of tracing

2. Artifact is present for more than 25% of the minute of tracing

3. Missing data or artifact prevents determination of baseline rate

1. \> 15 seconds of continuous missing tracing

2. Missing data is not continuous but is sufficiently frequent that the one minute segment of tracing could not be used to determine baseline rate

The total number of interpretable minutes of fetal heart tracing and the percentage of time with interpretable fetal heart tracing over the course of labor (Number of minutes with interpretable FHR/Total number of minutes in labor) will be calculated for each patient.

Secondary Outcome Measures
NameTimeMethod
Maternal outcomes - Length of laborHospitalization for labor, delivery, and recovery - 2-4 days

Length of labor recorded

Number of times fetal heart rate monitor requires adjusting:Time of randomization until time of delivery (up to 48 hours)

Number of times that hand holding of the monitor is required

Overall cost of care:Hospitalization for labor, delivery, and recovery - 2-4 days

Delivery type and indication

Number and quality of uterine contractions in each 10 minute segment:Time of randomization until time of delivery (up to 48 hours)

Signal quality (amount of missing data or artifact) will be recorded

Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode:Time of randomization until time of delivery (up to 48 hours)

Need for additional monitoring devices will be determined by the clinical care team including attending physician and/or nurses based on clinical judgment

Neonatal outcomes - Neonatal SexHospitalization after delivery - 2-4 days

Neonatal sex recorded

Patient and provider satisfaction - Nurse SurveyUp to 7 days after delivery

Satisfaction survey completed by nurse attending labor/delivery after delivery of infant

Quality and interpretability of the FHT in ten minute segmentsTime of randomization until time of delivery (up to 48 hours)

a. Each 10 minute segment will be deemed to be interpretable if it meets all of the following criteria: i. Sufficient data are available to determine a baseline ii. Sufficient data are available to determine the variability of the tracing iii. Sufficient data are available to identify periodic changes in the tracing (e.g. accelerations, decelerations, etc) b. For each 10 minute segment that is called Uninterpretable, the reviewer will indicate the reason for this designation by selecting one of the following options: i. Poor signal quality due to missing data ii. Poor signal quality due to artifact iii. Adequate signal quality but intrinsic fetal heart rate makes interpretation impossible (e.g. marked variability, etc.)

Nursing time required for care:Time of randomization until time of delivery (up to 48 hours)

Nurses will record the time and reasons that they enter the room

Maternal outcomes - Estimated blood lossHospitalization for labor, delivery, and recovery - 2-4 days

Amount of blood loss (cc) recorded

Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team:Time of randomization until time of delivery (up to 48 hours)

Reason 5: Provider preference

Maternal outcomes - Delivery typeHospitalization for labor, delivery, and recovery - 2-4 days

Type of delivery recorded (e.g., vaginal, cesarean section, etc.)

Maternal outcomes - Intra-amniotic infection (clinical chorioamnionitis or triple I)Hospitalization for labor, delivery, and recovery - 2-4 days

Infections documented

Neonatal outcomes - APGAR ScoresHospitalization after delivery - 2-4 days

APGAR scores recorded at 1 minute, 5 minutes, and 10 minutes

Neonatal outcomes - BirthweightHospitalization after delivery - 2-4 days

Infant birthweight (grams)

Patient and provider satisfaction - Patient SurveyUp to 7 days after delivery

Satisfaction survey completed by patient after delivery of infant

Maternal outcomes - Indication for forceps/vacuum extraction or cesarean section, if performedHospitalization for labor, delivery, and recovery - 2-4 days

Clinical indication for forceps/vacuum extraction or cesarean section delivery

Maternal outcomes - Presence and severity of perineal lacerationsHospitalization for labor, delivery, and recovery - 2-4 days

Lacerations and degree of laceration recorded

Maternal outcomes - Presence of clinical endometritisHospitalization for labor, delivery, and recovery - 2-4 days

Endometritis diagnosis recorded

Neonatal outcomes - Need for ICU AdmissionHospitalization after delivery - 2-4 days

Recorded NICU admission

Patient and provider satisfaction - Attending Physician/Midwife SurveyUp to 7 days after delivery

Satisfaction survey completed by physician/midwife attending labor/delivery after delivery of infant

Trial Locations

Locations (4)

Intermountain Medical Center

🇺🇸

Murray, Utah, United States

McKay-Dee Hospital

🇺🇸

Ogden, Utah, United States

LDS Hospital

🇺🇸

Salt Lake City, Utah, United States

Utah Valley Hospital

🇺🇸

Provo, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath